Elsevier Enhances SciVal Spotlight with Collaboration Analysis

Amsterdam, September 15, 2011 – As a rising number of institutions shift their focus towards collaborative relationships to secure funding in a more competitive research landscape, analyzing current and potential partners has become increasingly important. To address this growing need, Elsevier, a world-leading provider of scientific, technical and medical information products and services, has now launched a new enhancement to SciVal Spotlight: an integrated collaboration analysis enabling institutional decision makers to identify and evaluate partnerships at an institutional and author level.

This new enhancement allows users to identify and assess existing and potential partner institutions related to the current research competencies. Further, it enables the evaluation of existing partnerships by combined article output among contributing institutions and displays collaboration partners in particular research strengths. Ultimately, institutional decision makers can now find or evaluate existing and potential partners by uncovering with whom they are collaborating, with whom they are sharing and not sharing competencies, and who is active within competencies but is not yet a partner.

“Working with academic and governmental research advisors around the globe, we uncovered a growing demand for data driven methods to evaluate and enhance the strategic collaborative partnerships vital to securing competitive funding and increasing overall research excellence,” explained Jay Katzen, Managing Director of Elsevier Academic and Government Markets. “As part of our customer-centric approach, we work closely with development partners and customers to solicit feedback and leverage our agile development methodology to ensure we can rapidly address and improve our SciVal suite based on this feedback.”

The visual presentation of the collaboration landscape based on user selected criteria can be displayed in three ways:

For more information on SciVal Spotlight, please visit www.info.scival.com.

# # #

About the Elsevier SciVal® Suite
Elsevier’s SciVal suite of services supports academic and government leadership in evaluating, establishing and executing research strategies that optimize the performance of existing assets and maximize investments to enhance near and long-term productivity. SciVal tools leverage Scopus® data, Elsevier’s trusted source of bibliometric data, to offer innovative yet authoritative solutions. Current suite offerings include: SciVal Spotlight™, a strategic tool that generates unique institutional and country maps of existing and emerging research strengths based on an interdisciplinary perspective of current performance; SciVal Funding™, an online solution that provides targeted recommendations on grants to pursue based on pre-populated research profiles and historical awards; SciVal Strata™, a web-based research performance tool that offers users the flexibility to construct relevant contextual data to evaluate research teams or individual researchers, using a range of indicators based on Scopus data; SciVal Experts™, a semantic technology-based application that enables researchers to identify and locate sources of expertise at an individual or departmental level within and across institutions.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Sandra Plasse
+ 1 212 752 8338
splasse@psbpr.com